Discontinuation report PROSTIN F2 ALPHA
| Report ID | 48996 |
| Drug Identification Number | 00318736 |
| Brand name | PROSTIN F2 ALPHA |
| Common or Proper name | PROSTIN F2A |
| Company Name | PFIZER CANADA ULC |
| Market Status | CANCELLED POST MARKET |
| Active Ingredient(s) | DINOPROST |
| Strength(s) | 5MG |
| Dosage form(s) | SOLUTION |
| Route of administration | INTRA-AMNIOTIC |
| Packaging size | 1 x 1ml |
| ATC code | G02AD |
| ATC description | UTEROTONICS |
| Reason for discontinuation | Other (Please describe in comments) |
| Anticipated discontinuation date | |
| Actual discontinuation date | 2018-09-30 |
| Remaining supply date | 2018-09-30 |
| Discontinuation status | Discontinued |
| Discontinuation decision reversal | No |
| Information on remaining supply | |
| Company comments | The product discontinuation is due to low market demand. |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 17300 TRANS-CANADA HIGHWAY KIRKLAND, QUEBEC CANADA H9J 2M5 |
| Company contact information | Customer Service / service à la clientèle : 1-888-999-8750 Email / courriel: [email protected] |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v4 | 2019-02-11 | French | Compare |
| v3 | 2019-02-11 | English | Compare |
| v2 | 2018-05-10 | French | Compare |
| v1 | 2018-05-10 | English | Compare |
Showing 1 to 4 of 4